Sunesis Pharmaceuticals Inc - Current report filing (8-K)
11 March 2008 - 11:38PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC
20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported):
March
11, 2008
SUNESIS
PHARMACEUTICALS, INC.
|
|
(Exact
Name of Registrant as Specified in its
Charter)
|
|
|
|
Delaware
|
000-51531
|
94-3295878
|
(State
or Other Jurisdiction
|
(Commission
|
(IRS
Employer
|
of
Incorporation)
|
File
Number)
|
Identification
No.)
|
|
|
341
Oyster Point Boulevard
South
San Francisco, California
|
94080
|
(Address
of Principal Executive Offices)
|
(Zip
Code)
|
Registrant’s
telephone number, including area code:
(650)
266-3500
|
Not
Applicable
|
(Former
Name or Former Address, if Changed Since Last Report.)
|
|
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (
see
General Instruction A.2. below):
[
] Written communications pursuant to Rule 425 under the Securities Act (17
CFR
230.425)
[
] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[
] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
[
] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
Item
2.02. Results of Operations & Financial Condition.
On
March
11, 2008, Sunesis Pharmaceuticals, Inc. issued a press release announcing its
financial results for the fourth quarter and full year ended December 31, 2007.
A copy of the press release is attached hereto as Exhibit 99.1
Item
9.01. Financial Statements and Exhibits.
Exhibit
No
.
|
Description
|
|
|
99.1
|
Press
release issued by Sunesis Pharmaceuticals, Inc., dated March 11,
2008.
|
*
* * * *
* * * *
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
SUNESIS
PHARMACEUTICALS, INC.
|
|
|
|
|
|
|
Date:
March 11, 2008
|
|
|
|
By:
|
/s/
ERIC H. BJERKHOLT
|
|
|
Eric
H. Bjerkholt
|
|
|
Senior
Vice President, Corporate Development and Finance
|
EXHIBIT
INDEX
Exhibit
No
.
|
Description
|
|
|
99.1
|
Press
release issued by Sunesis Pharmaceuticals, Inc., dated March
11,
2008.
|
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Sep 2024 to Oct 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Oct 2023 to Oct 2024
Real-Time news about Sunesis Pharmaceuticals Inc (NASDAQ): 0 recent articles
More Sunesis Pharmaceuticals Inc News Articles